Abstract:Objective: To determine the one-year mortality and incidence of myocardial infarction (MI) post-hospital discharge or ED release for patients with cocaine-associated chest pain.Methods: A prospective, observational study of an inception cohort of consecutive patients who presented to one of four municipal hospital EDs with cocaine-associated chest pain. Patients were followed for one year from the end of the enrollment period. Main outcome parameters were the one-year actuarial survival and the frequency of no… Show more
“…In another cohort of 203 patients with cocaine-associated chest pain followed up for 1 year, 60% reported continued cocaine use. 39 Although no MI or death occurred among those claiming abstinence, 2 nonfatal MIs and 6 deaths occurred in patients with persistent cocaine use (although none were attributed to MI). Weber et al 49 reported a 1.6% rate of nonfatal MI during a 30-day follow-up of patients who presented with cocaine-associated chest pain and in whom MI was excluded.…”
Section: Complications and Prognosismentioning
confidence: 99%
“…Recurrent chest pain is less common and MI and death are rare among patients who discontinue cocaine. 39,49 No established drug treatments exist for cocaine dependency, however, and recidivism is high among patients with cocaine-associated chest pain (60% admit to cocaine use in the next year). 39 Several options for psychosocial intervention exist, including individual and group counseling, psychotherapy, and cognitive therapy.…”
Section: Discharge Management and Secondary Preventionmentioning
confidence: 99%
“…39,49 No established drug treatments exist for cocaine dependency, however, and recidivism is high among patients with cocaine-associated chest pain (60% admit to cocaine use in the next year). 39 Several options for psychosocial intervention exist, including individual and group counseling, psychotherapy, and cognitive therapy. Preliminary data suggest that a combination of intensive group and individual drug counseling has the greatest impact on recurrent cocaine use.…”
Section: Discharge Management and Secondary Preventionmentioning
confidence: 99%
“…Postdischarge use of -blockers, although clearly beneficial among patients with previous MI and cardiomyopathy who do not abuse cocaine, merits special consideration in the setting of cocaine abuse. Because recidivism is high among patients with cocaine-associated chest pain, 39 chronic -blocker use should be reserved for those with the strongest indications, including those with documented MI, left ventricular systolic dysfunction, or ventricular arrhythmias, in whom the benefits may outweigh the risks even among patients at risk for recurrent use of cocaine. This decision should be individualized on the basis of careful risk-benefit assessment and after counseling the patient about the potential negative interactions between recurrent cocaine use and -blockade.…”
Section: Discharge Management and Secondary Preventionmentioning
“…In another cohort of 203 patients with cocaine-associated chest pain followed up for 1 year, 60% reported continued cocaine use. 39 Although no MI or death occurred among those claiming abstinence, 2 nonfatal MIs and 6 deaths occurred in patients with persistent cocaine use (although none were attributed to MI). Weber et al 49 reported a 1.6% rate of nonfatal MI during a 30-day follow-up of patients who presented with cocaine-associated chest pain and in whom MI was excluded.…”
Section: Complications and Prognosismentioning
confidence: 99%
“…Recurrent chest pain is less common and MI and death are rare among patients who discontinue cocaine. 39,49 No established drug treatments exist for cocaine dependency, however, and recidivism is high among patients with cocaine-associated chest pain (60% admit to cocaine use in the next year). 39 Several options for psychosocial intervention exist, including individual and group counseling, psychotherapy, and cognitive therapy.…”
Section: Discharge Management and Secondary Preventionmentioning
confidence: 99%
“…39,49 No established drug treatments exist for cocaine dependency, however, and recidivism is high among patients with cocaine-associated chest pain (60% admit to cocaine use in the next year). 39 Several options for psychosocial intervention exist, including individual and group counseling, psychotherapy, and cognitive therapy. Preliminary data suggest that a combination of intensive group and individual drug counseling has the greatest impact on recurrent cocaine use.…”
Section: Discharge Management and Secondary Preventionmentioning
confidence: 99%
“…Postdischarge use of -blockers, although clearly beneficial among patients with previous MI and cardiomyopathy who do not abuse cocaine, merits special consideration in the setting of cocaine abuse. Because recidivism is high among patients with cocaine-associated chest pain, 39 chronic -blocker use should be reserved for those with the strongest indications, including those with documented MI, left ventricular systolic dysfunction, or ventricular arrhythmias, in whom the benefits may outweigh the risks even among patients at risk for recurrent use of cocaine. This decision should be individualized on the basis of careful risk-benefit assessment and after counseling the patient about the potential negative interactions between recurrent cocaine use and -blockade.…”
Section: Discharge Management and Secondary Preventionmentioning
“…The differential diagnosis of cocaine-related chest pain is broad and includes acute coronary syndrome (ACS), aortic dissection, pneumothorax, pneumomediastinum, pneumopericardium, and pulmonary infarction [3][4][5][6][7][8]. Diagnostic and treatment strategies are similar to that of other ED patients with chest pain.…”
INTRODUCTIONCocaine abuse accounts for over 64,000 ED visits annually, of which more than 50% are chest pain related [1,2]. The differential diagnosis of cocaine-related chest pain is broad and includes acute coronary syndrome (ACS), aortic dissection, pneumothorax, pneumomediastinum, pneumopericardium, and pulmonary infarction [3][4][5][6][7][8]. Diagnostic and treatment strategies are similar to that of other ED patients with chest pain. However, when considering the therapy of CAACS, strategies differ. For cocaine exposure, coronary artery vasoconstriction is mediated by alphaadrenergic stimulation [5]. We are presenting the second published case of CAACS with electrocardiogram (ECG) abnormalities that resolved when the use of an alpha-adrenergic receptor antagonist, phentolamine, was implemented.
CASE REPORTA 43-year-old man with a history of depression presented to the emergency department (ED) with a chief complaint of left sided chest pain that began 1 hour after insufflating cocaine. The pain was described as an intense ache that was a "10 out of 10" in terms of its intensity, and it radiated to his left shoulder. He attempted to alleviate his symptoms by drinking ethanol to "bring him down" but this was unsuccessful at relieving the pain. A similar event happened two weeks prior, also during cocaine use, and the patient was admitted to a hospital and diagnosed with CAACS. His evaluation (including serum troponin levels over a 24-hour period, echocardiogram, and exercise stress test) was normal. He was discharged on aspirin, diltiazem, nitroglycerin, and referred to a Case report: We are reporting on the treatment of a patient with cocaine-associated acute coronary syndrome (CAACS) who did not benefit from standard therapy, but who eventually responded positively to phentolamine, an alpha-adrenergic receptor antagonist.Discussion: This report should encourage physicians to add phentolamine to their pharmacotherapeutic armamentarium in the treatment of CAACS.
Patients with chest pain often are not asked about recent cocaine use. When they are asked, their answers are poorly documented. These findings cannot be explained by poor recall. In cases of chest pain, efforts to improve questioning of patients about cocaine use are needed, since recent cocaine use may change treatment, disposition, and need for counseling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.